Health officials would like to remind you that we are entering that time of the year still quaintly known as flu season. That ...

Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...

First flu-related death of 2024-2025 flu season reported in North Carolina. NCDHHS recommends vaccinations and protective ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

A new analysis from Imperial's human challenge study of COVID-19 has revealed subtle differences in the memory and cognition ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

Highlights:,Merck & Co Inc's experimental treatment, clesrovimab, has demonstrated positive results in a mid- to late-stage ...

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

Facilities will be required to “implement and enforce a program requiring healthcare workers, regardless of vaccination ...

Colorado's health department is working to get more information out to the public about circulating respiratory viruses. It’s ...

Respiratory virus infections in symptomatic and asymptomatic children upon hospital admission: new insights - Volume 4 Issue ...

The next-generation sequencing test, infexn, developed by HaystackAnalytics, is a genomics-based test capable of detecting ...